Reports

      Immediate test-retest reliabilities of intention to quit smoking measures in current adult smokers

      Mainy, N.; Dibenedetto, S.; Hankins, M.; AlMoosawi, S.; Clerc, E.; Kallischnigg, G.; Sieverding, M.; Magnani, P.

      Published on
      Sep 30, 2022
      DOI
      10.32388/MZ3COF
      Link to publication
      Topic
      Summary

      Background: The Stages of Change (SOC) measure and Motivation To Stop Scale (MTSS) are regularly used to capture current smokers’ intention to quit (ITQ) cigarette smoking. They were shown to have comparable performances in construct and predictive validity, but their immediate test-retest reliabilities have not been investigated. In this randomized online two-arm study, we examined the immediate test-retest reliability of both SOC and MTSS measures.

      Methods: Adult current smokers were randomized to complete an electronic version of either the SOC or MTSS, which was filled out before and after completing a filler task. Test-retest reliability was assessed with Cohen’s kappa coefficients. Intraclass correlation coefficients (ICC) were calculated as an index of reliability for the MTSS, when expressed as a continuous variable.

      Results: A total of 722 participants were included in the analyses, with 311 and 411 completing the SOC and MTSS, respectively. The two measures showed high reliability; Cohen’s kappa coefficients of the ITQ measures ranged from 0.73 to 0.95, corresponding to substantial agreement up to “almost perfect” or “perfect” agreement. The ICC coefficient for the MTSS was 0.86, corresponding to excellent agreement.

      Conclusions: Both measures have good test-retest reliability over a brief time interval. Instrument selection should be driven by the specific study objective and whether the investigation is intended to measure ITQ specifically or more broadly.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.